DrugDashboards

infliximab-dyyb

infliximab-dyyb · INFLIXIMAB-DYYB 100 mg/10mL · Injection, Powder, Lyophilized, For Solution · CELLTRION, Inc.

NDC 32228-0001-03 · 750 VIAL, SINGLE-USE in 1 BOX / 10 mL in 1 VIAL, SINGLE-USE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $5,418.47 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of infliximab-dyyb (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
CELLTRION, Inc.INFLIXIMAB-DYYB 100 mg/10mLJul 15, 2026Sep 2, 2026
CELLTRION, Inc.INFLIXIMAB-DYYB 9 kg/9kgJul 15, 2026Sep 2, 2026
Pfizer Laboratories Div Pfizer IncINFLIXIMAB 100 mg/10mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "infliximab-dyyb — NDC 32228-0001-03," retrieved September 3, 2026, https://drugdashboards.com/drug/32228000103.

Free to cite with attribution — see how the data is put together.